In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

For 2001, A Top Eleven List

Executive Summary

2001 was a mixed year for health-care manufacturers, characterized by real advances in cardiac device therapies, the maturing of the biotech and generics sectors, and the continued embattlement of Big Pharma. Here's the staff of IN VIVO's list of the most important trends.
Advertisement

Related Content

Biotech's Holiday Shopping Spree--Buy, Buy, Buy
Is Product Infatuation the Death Knell for Platforms?
In Two Recent Trials, Devices Trump Rx
The Dawning of the Life Sciences Defense Industry
Beyond Drug-Coated Stents
The Search for Certainty: Trends in Early- and Late-Stage Dealmaking
A Gun-Shy FDA?
Protein C: Saving Lives, Saving Lilly

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV001766

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel